Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noushin Dianat

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Biologie Aujourd'Hui|June 12, 2016
[Human pluripotent stem cells and liver disorders]Noushin Dianat, Anne Weber, Anne Dubart-Kupperschmitt
Current Gene Therapy|March 1, 2013
Human pluripotent stem cells for modelling human liver diseases and cell therapyNoushin Dianat, Clara Steichen, Ludovic Vallier, et al.
Journal of Hepatology|February 27, 2016
The potential of induced pluripotent stem cell derived hepatocytesZara Hannoun, Clara Steichen, Noushin Dianat, et al.
Molecular Cancer Therapeutics|December 11, 2014
Midkine lacking its last 40 amino acids acts on endothelial and neuroblastoma tumor cells and inhibits tumor developmentNoushin Dianat, Barbara Le Viet, Emilie Gobbo, et al.
Frontiers in Bioengineering and Biotechnology|June 18, 2025
Optimising and adapting perfusion feeds in serum-free medium to intensify CAR-T cell expansion in stirred-tank bioreactorsPierre Springuel, Tiffany Hood, Fern Slingsby, et al.
Stem Cells Translational Medicine|February 5, 2015
An atypical human induced pluripotent stem cell line with a complex, stable, and balanced genomic rearrangement including a large de novo 1q uniparental disomyClara Steichen, Jérôme Maluenda, Lucie Tosca, et al.
Hepatology (Baltimore, Md.)|April 10, 2014
Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cellsNoushin Dianat, Hélène Dubois-Pot-Schneider, Clara Steichen, et al.
Bioengineering & Translational Medicine|May 19, 2025
Establishing a scalable perfusion strategy for the manufacture of CAR-T cells in stirred-tank bioreactors using a quality-by-design approachTiffany Hood, Pierre Springuel, Fern Slingsby, et al.
Frontiers in Immunology|April 24, 2024
A quality-by-design approach to improve process understanding and optimise the production and quality of CAR-T cells in automated stirred-tank bioreactorsTiffany Hood, Fern Slingsby, Viktor Sandner, et al.
Cytotherapy|May 12, 2025
Scaling up pluripotent stem cell-based therapies - considerations, current challenges and emerging technologies: perspectives from the ISCT Emerging Regenerative Medicine Working GroupNatalie Francis, Joy Aho, Inbar Friedrich Ben-Nun, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Biologie Aujourd'Hui|June 12, 2016
[Human pluripotent stem cells and liver disorders]Noushin Dianat, Anne Weber, Anne Dubart-Kupperschmitt
Current Gene Therapy|March 1, 2013
Human pluripotent stem cells for modelling human liver diseases and cell therapyNoushin Dianat, Clara Steichen, Ludovic Vallier, et al.
Journal of Hepatology|February 27, 2016
The potential of induced pluripotent stem cell derived hepatocytesZara Hannoun, Clara Steichen, Noushin Dianat, et al.
Molecular Cancer Therapeutics|December 11, 2014
Midkine lacking its last 40 amino acids acts on endothelial and neuroblastoma tumor cells and inhibits tumor developmentNoushin Dianat, Barbara Le Viet, Emilie Gobbo, et al.
Frontiers in Bioengineering and Biotechnology|June 18, 2025
Optimising and adapting perfusion feeds in serum-free medium to intensify CAR-T cell expansion in stirred-tank bioreactorsPierre Springuel, Tiffany Hood, Fern Slingsby, et al.
Stem Cells Translational Medicine|February 5, 2015
An atypical human induced pluripotent stem cell line with a complex, stable, and balanced genomic rearrangement including a large de novo 1q uniparental disomyClara Steichen, Jérôme Maluenda, Lucie Tosca, et al.
Hepatology (Baltimore, Md.)|April 10, 2014
Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cellsNoushin Dianat, Hélène Dubois-Pot-Schneider, Clara Steichen, et al.
Bioengineering & Translational Medicine|May 19, 2025
Establishing a scalable perfusion strategy for the manufacture of CAR-T cells in stirred-tank bioreactors using a quality-by-design approachTiffany Hood, Pierre Springuel, Fern Slingsby, et al.
Frontiers in Immunology|April 24, 2024
A quality-by-design approach to improve process understanding and optimise the production and quality of CAR-T cells in automated stirred-tank bioreactorsTiffany Hood, Fern Slingsby, Viktor Sandner, et al.
Cytotherapy|May 12, 2025
Scaling up pluripotent stem cell-based therapies - considerations, current challenges and emerging technologies: perspectives from the ISCT Emerging Regenerative Medicine Working GroupNatalie Francis, Joy Aho, Inbar Friedrich Ben-Nun, et al.
Pageof 2